Variation in COVID-19 booster uptake in England: An ecological study

被引:3
|
作者
Dropkin, Greg
机构
[1] Independent Researcher, Liverpool
来源
PLOS ONE | 2022年 / 17卷 / 06期
关键词
D O I
10.1371/journal.pone.0270624
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction Variable and low uptake of the COVID-19 booster is a recognised problem, associated with individual characteristics including age, gender, ethnicity, and deprivation. Are there other relevant predictors at area level? Methods Anonymous grouped data was downloaded from the UK Government Coronavirus Dashboard for Middle Super Output Areas (MSOA) in England, along with demographic, employment, and health data from public sources. Mixed models with a random intercept for Upper Tier Local Authority were analysed as quasibinomial Generalized Additive Models. The estimated random effects were then fitted with Bayesian linear mixed models using flu vaccination uptake, change in public health budgets, population proportion of vaccination sites at pharmacies, GP-led, vaccination centres, and hospital hubs, and Region. Results Models for the MSOA-level COVID-19 first and second vaccinations and the Third Injection (including the booster), fit well. Index of Multiple Deprivation, proportion Aged 15-24 and 25-44, and ethnicity groupings Other White, Indian-Pakistani-Bangladeshi, and African-Caribbean-Other Black-Other, are highly significant predictors of lower uptake. The estimated random effects vary widely amongst local authorities, with positive impact of flu vaccine uptake and change in public health budgets, and regional impacts which are positive for London and South East (first and second doses only), and negative for North West and North East. The impact of vaccination sites did not reach 90% credibility, in general. Conclusion COVID-19 vaccination rates at each stage are very well modelled if local authority random effects are included along with non-linear terms for demographic, employment and health data. Deprivation, younger age, and Other White, South Asian, and African-Caribbean-Other ethnicities are associated with lower uptake. The estimated local effects show strong regional variation and are positively associated with flu vaccination and increasing public health budgets. One simple way to improve COVID-19 vaccine uptake in England would be to increase local public health allocations.
引用
收藏
页数:20
相关论文
共 50 条
  • [41] A qualitative study exploring attitudes and perceptions of the COVID-19 booster vaccine in minority ethnic individuals in North East England
    Eberhardt, Judith
    Kabuye, John
    Ling, Jonathan
    JOURNAL OF PUBLIC HEALTH-HEIDELBERG, 2024, 32 (05): : 765 - 775
  • [42] A qualitative study exploring attitudes and perceptions of the COVID-19 booster vaccine in minority ethnic individuals in North East England
    Judith Eberhardt
    John Kabuye
    Jonathan Ling
    Journal of Public Health, 2024, 32 : 765 - 775
  • [43] COVID-19 booster vaccine uptake and reduced risks for long-COVID: A cross-sectional study of a US adult population
    Xie, Zhigang
    Stallings-Smith, Sericea
    Patel, Shraddha
    Case, Stuart
    Hong, Young -Rock
    VACCINE, 2024, 42 (16) : 3529 - 3535
  • [44] Novavax COVID-19 Vaccine Booster Authorized
    Larkin, Howard D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (21): : 2101 - 2101
  • [45] Booster Vaccination Strategies for "Living With COVID-19"
    Kim, Jung Eun
    Lee, Sunmi
    Kim, Hee-Sung
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [46] Residential Segregation and County-Level COVID-19 Booster Coverage in the Deep South: Surveillance Report and Ecological Study
    Zeng, Chengbo
    Zhang, Jiajia
    Li, Zhenlong
    Sun, Xiaowen
    Ning, Huan
    Yang, Xueying
    Weissman, Sharon
    Olatosi, Bankole
    Li, Xiaoming
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2023, 9
  • [47] Homologous and Heterologous Covid-19 Booster Vaccinations
    Atmar, R. L.
    Lyke, K. E.
    Deming, M. E.
    Jackson, L. A.
    Branche, A. R.
    El Sahly, H. M.
    Rostad, C. A.
    Martin, J. M.
    Johnston, C.
    Rupp, R. E.
    Mulligan, M. J.
    Brady, R. C.
    Frenck, R. W., Jr.
    Backer, M.
    Kottkamp, A. C.
    Babu, T. M.
    Rajakumar, K.
    Edupuganti, S.
    Dobrzynski, D.
    Coler, R. N.
    Posavad, C. M.
    Archer, J., I
    Crandon, S.
    Nayak, S. U.
    Szydlo, D.
    Zemanek, J. A.
    Islas, C. P. Dominguez
    Brown, E. R.
    Suthar, M. S.
    McElrath, M. J.
    McDermott, A. B.
    Montefiori, D. C.
    Eaton, A.
    Neuzil, K. M.
    Stephens, D. S.
    Roberts, P. C.
    Beigel, J. H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (11): : 1046 - 1057
  • [48] Predicting COVID-19 booster vaccine intentions
    Hagger, Martin S.
    Hamilton, Kyra
    APPLIED PSYCHOLOGY-HEALTH AND WELL BEING, 2022, 14 (03) : 819 - 841
  • [49] COVID-19 vaccine equity and booster doses
    LANCET INFECTIOUS DISEASES, 2021, 21 (09): : 1193 - 1193
  • [50] Evaluation of COVID-19 Booster Vaccine Effectiveness
    Qu, Bingqian
    Zhang, Dingmei
    VIRUSES-BASEL, 2025, 17 (02):